Skip to main content
Monday 11 December 2023
twitter linkedin facebook rss
User account menu
  • Sign up
Home
Pharmaphorum menu first category
  • News
  • Views & Analysis
  • Deep Dive
  • Webinars
  • Podcasts
  • Videos
  • White Papers
  • Events
Pharmaphorum
close
    SECTION
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Videos
    • White Papers
    • Events
Channels
    Channels
    • Sales & Marketing
    • R&D
    • Digital
    • Market Access
    • Oncology
    • Patients
    • Spotlight
Channels
  • Sales & Marketing
  • R&D
  • Digital
  • Market Access
  • Oncology
  • Patients
  • Spotlight
    SUB NAVIGATION
    • Live Coverage
    • Partner Content
    • About us
    • Work for us
    • Contribute
    • Contact us
    • Advertise

Newsletters and Deep Dive digital magazine

 
 
Sign up
twitter linkedin facebook rss
Sign in

usa

Views & Analysis
Biden administration – What can the healthcare industry expect

Biden administration – What can the healthcare industry expe...

As Joe Biden takes the reins at the White House, pharmaphorum asks experts how his presidential tenure may influence the global healthcare industry.

News
moderna

US government gives Moderna $483m for COVID-19 vaccine

News
Johnsons-baby-powder-1200x675

Jury trial levies $750m damages on J&J over talc and cancer

News
Capitol Hill

As election year looms, Democrats lever drug pricing bill th...

News
Congress_wikipedia_commons

US eyes faster launch for biosimilars in North American trad...

News
1024px-img_2259_-_washington_dc_-_us_capitol

Democrats unveil price plan targeting 250 big-spend drugs

  • Load more results

Editor's Picks

  1. AbbVie agrees $10.1bn deal to buy ImmunoGen
  2. UK Biobank releases largest-ever genome sequencing dataset
  3. EVERSANA brings GenAI to medical content approvals
  4. Experts allay fears over pneumonia outbreak in China
  5. Could high HDL-cholesterol raise dementia risk?
News
Vertex Pharmaceutical's Boston headquarters

FDA clears two sickle-cell gene therapies, including CRISPR ...

The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.

on demand
R&D
Revolutionising research: Inside the NCVR evolution in the UK
Sponsored

Revolutionising research: Inside the NCVR evolution in the U...

On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio

Pharmaphorum Menu
  • Digital
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Market Access
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Oncology
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Patients
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • R&D
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Sales & Marketing
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Spotlight on
    • The Future of Generics
    • Frontiers Health 2023
    • World Without Disease Summit

Sign up for email newsletters and Deep Dive

 
 
rss facebook linkedin twitter
Pharmaphorum
About us Advertising Contact us
Contribute Cookie Policy Privacy Policy
Terms & Conditions Work for us
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company